On the optimal choice of the exposure conditions and the nanoparticle features in magnetic nanoparticle hyperthermia

References

• Pankhurst QA, Connolly J, Jones SK, Dobson J. Applications of magnetic nanoparticles in biomedicine. J Phys D: Appl Phys 2003; 36: R167–R181
   Web of Science ®Google Scholar
• Leslie-Pelecky DL, Labhasetwar V, Kraus RH. Nanobiomagnetics. Advanced magnetic nanostructures, DJ Sellmyer, Skomski, R. Springer, New York 2006; 461–490
   Google Scholar
• Thiesen B, Jordan A. Clinical applications of magnetic nanoparticles for hyperthermia. Int J Hyperthermia 2008; 24: 467–474
   PubMed Web of Science ®Google Scholar
• Jordan A, Scholz R, Wust P, Fahling H, Felix R. Magnetic fluid hyperthermia (MFH): cancer treatment with AC magnetic field induced excitation of biocompatible superparamagnetic nanoparticles. J Magn Magn Mater 1999; 201: 413–419
   Web of Science ®Google Scholar
• Gazeau F, Lévy M, Wilhelm C. Optimizing magnetic nanoparticle design for nonothermotherapy. Nanomedicine 2008; 3: 831–844
   PubMed Web of Science ®Google Scholar
• Barry SE. Challenges in the development of magnetic particles for therapeutic applications. Int J Hyperthermia 2008; 24: 451–466
   PubMed Web of Science ®Google Scholar
• Jordan A, Scholz R, Maier-Hauff K, Johannsen M, Wust P, Nadobny J, Schirra H, Schmidt H, Deger S, Loening SA, et al. Presentation of a new magnetic field therapy system for the treatment of human solid tumors with magnetic fluid hyperthermia. J Magn Magn Mater 2001; 225: 118–126
   Web of Science ®Google Scholar
• Rosensweig RE. Heating magnetic fluid with alternating magnetic field. J Magn Magn Mater 2002; 252: 370–374
   Web of Science ®Google Scholar
• Hergt R, Dutz S, Roder M. Effect of size distribution on hysteresis losses of magnetic nanoparticles for hyperthermia. J Phys: Condens Matter 2008; 20: 1–12
   Web of Science ®Google Scholar
• DeNardo SJ, DeNardo GL, Natarajan A, Miers LA, Foreman AR, Gruettner C, Adamson GN, Ivkov R. Thermal dosimetry predictive of efficacy of 111In-ChL6 nanoparticle AMF-induced thermoablative therapy for human breast cancer in mice. J Nucl Med 2007; 48: 437–444
   PubMed Web of Science ®Google Scholar
• Johannsen M, Gneveckow U, Eckelt L, Feussner A, Waldofner N, Scholz R, Deger S, Wust P, Loening SA, Jordan A. Clinical hyperthermia of prostate cancer using magnetic nanoparticles: Presentation of a new interstitial technique. Int J Hyperthermia 2005; 21: 1–11
   PubMedGoogle Scholar
• Johannsen M, Gneveckow U, Taymoorian K, Thiesen B, Waldöfner N, Scholz R, Jung K, Jordan A, Wust P, Loening SA. Morbidity and quality of life during thermotherapy using magnetic nanoparticles in locally recurrent prostate cancer: Results of a prospective phase I trial. Int J Hyperthermia 2007; 23: 315–323
   PubMed Web of Science ®Google Scholar
• Hildebrandt B, Schoeler D, Ringel F, Kerner T, Wust P, Riess H, Schriever F. Differential gene expression in peripheral blood lymphocytes of cancer patients treated with whole body hyperthermia and chemotherapy: A pilot study. Int J Hyperthermia 2006; 22: 625–635
   PubMed Web of Science ®Google Scholar
• Atsarkin VA, Levkin LV, Posvyanskiy VS, Melnikov OV, Markelova MN, Gorbenko OY, Kaul AR. Solution to the bioheat equation for hyperthermia with La1-xAgyMnO3-δ nanoparticles: The effect of temperature autostabilization. Int J Hyperthermia 2009; 25: 240–247
   PubMed Web of Science ®Google Scholar
• Hergt R, Dutz S. Magnetic particle hyperthermia–Biophysical limitations of a visionary tumour therapy. J Magn Magn Mater 2007; 311: 187–192
   Web of Science ®Google Scholar
• Brusentsov NA, Gogosov V, Brusentsova TN, Sergeev AV, Jurchenko NY, Kuznetsov AA, Kuznetsov OA, Shumakov LI. Evaluation of ferromagnetic fluids and suspensions for the site-specific radiofrequency-induced hyperthermia of MX11 sarcoma cells in vitro. J Magn Magn Mater 2001; 225: 113–117
   Web of Science ®Google Scholar
• Jordan A, Wust P, Scholz R, Tesche B, Fähling H, Mitrovics T, Vogl T, Cervós-navarro J, Felix R. Cellular uptake of magnetic fluid particles and their effects on human adenocarcinoma cells exposed to AC magnetic fields in vitro. Int J Hyperthermia 1996; 12: 705–722
   PubMed Web of Science ®Google Scholar
• Zhai Y, Xie H, Gu H. Effects of hyperthermia with dextran magnetic fluid on the growth of grafted H22 tumour in mice. Int J Hyperthermia 2009; 25: 65–71
   PubMed Web of Science ®Google Scholar
• Jordan A, Maier-Hauff K. Magnetic nanoparticles for intracranial thermotherapy. J Nanosci Nanotechnol 2007; 7: 4604–4606
   PubMed Web of Science ®Google Scholar
• Wust P, Gneveckow U, Johannsen M, Böhmer D, Henkel T, Kahmann F, Sehouli J, Felix R, Ricke J, Jordan A. Magnetic nanoparticles for interstitial thermotherapy–Feasibility, tolerance and achieved temperatures. Int J Hyperthermia 2006; 22: 673–685
   PubMed Web of Science ®Google Scholar
• Hergt R, Dutz S, Muller R, Zeisberger M. Magnetic particle hyperthermia: Nanoparticle magnetism and materials development for cancer therapy. J Phys: Condens Matter 2006; 18: S2919–S2934
   Web of Science ®Google Scholar
• Glockl G, Hergt R, Zeisberger M, Dutz S, Nagel S, Weitschies W. The effect of field parameters, nanoparticle properties and immobilization on the specific heating power in magnetic particle hyperthermia. J Phys: Condens Matter 2006; 18: S2935–S2949
   Web of Science ®Google Scholar
• Brezovich IA. Low frequency hyperthermia. Med Phys Monograph 1988; 16: 82–111
   Google Scholar
• Arkin H, Xu LX, Holmes KR. Recent developments in modeling heat transfer in blood perfused tissues. IEEE Trans Biomed Eng 1994; 41: 97–107
   PubMed Web of Science ®Google Scholar
• Lv YG, Deng ZS, Liu J. 3-D numerical study on the induced heating effects of embedded micro/nanoparticles on human body subject to external medical electromagnetic field. IEEE Trans Nanobioscience 2005; 4: 284–294
   PubMed Web of Science ®Google Scholar
• Bagaria HG, Johnson DT. Transient solution to the bioheat equation and optimization for magnetic fluid hyperthermia treatment. Int J Hyperthermia 2005; 21: 57–75
   PubMed Web of Science ®Google Scholar
• Salloum M, Ma R, Zhu L. An in vivo experimental study of temperature elevations in animal tissue during magnetic nanoparticle hyperthermia. Int J of Hyperthermia 2008; 24: 589–601
   PubMed Web of Science ®Google Scholar
• Pavel M, Gradinariu G, Stancu A. Study of the optimum dose of ferromagnetic nanoparticles suitable for cancer therapy using MFH. IEEE Trans Magn 2008; 44: 3205–3208
   Web of Science ®Google Scholar
• Zhang C, Johnson DT, Brazel CS. Numerical study on the multi-region bio-heat equation to model magnetic fluid hyperthermia (MFH) using low Curie temperature nanoparticles. IEEE Trans Nanobioscience 2008; 7: 267–275
   PubMedGoogle Scholar
• Lang J, Erdmann B, Seebass M. Impact of nonlinear heat transfer on temperature control in regional hyperthermia. IEEE Trans Biomed Eng 1999; 46: 1129–1138
   PubMed Web of Science ®Google Scholar
• Kowalski ME, Jin JM. Model-based optimization of phased arrays for electromagnetic hyperthermia. IEEE Trans Microwave Theory Tech 2004; 52: 1964–1977
   Web of Science ®Google Scholar
• Candeo A, Dughiero F. Numerical FEM models for the planning of magnetic induction hyperthermia treatments with nanoparticles. IEEE Trans Magn 2009; 45: 1658–1661
   Web of Science ®Google Scholar
• Severens NMW, Van Marken Lichtenbelt WD, Frijns AJH, Van Steenhoven AA, De Mol BAJM, Sessler DI. A model to predict patient temperature during cardiac surgery. Phys Med Biol 2007; 52: 5131–5145
   PubMedGoogle Scholar
• Rai KN, Rai SK. Effect of metabolic heat generation and blood perfusion on the heat transfer in the tissues with a blood vessel. Heat Mass Trans 1999; 35: 75–79
   Google Scholar
• Fortin JP, Wilhelm C, Servais J, Ménager C, Bacri JC, Gazeau F. Size-sorted anionic iron oxide nanomagnets as colloidal mediators for magnetic hyperthermia. J Am Chem Soc 2007; 129: 2628–2635
   PubMed Web of Science ®Google Scholar
• Gonzales-Weimuller M, Zeisberger M, Krishnan KM. Size-dependent heating rates of iron oxide nanoparticles for magnetic fluid hyperthermia. J Magn Magn Mater 2009; 321: 1947–1950
   PubMed Web of Science ®Google Scholar
• Skumiel A, Jòzefczak A, Hornowski T. Investigation of magnetic and hyperthermic effects in ferrofluids with PEG biocompatible surfactant. J Phys: Conference Series 2009; 149: 1–4
   Google Scholar
• Fujita S, Tamazawa M, Kuroda K. Effects of blood perfusion rate on the optimization of RF-capacitive hyperthermia. IEEE Trans Biomed Eng 1998; 45: 1182–1186
   PubMed Web of Science ®Google Scholar
• Muffin MD, St Jeor ST, Hill LA, Scott BJ, Daugherty SA, Koh YO. A new predictive equation for resting energy expenditure in healthy individuals. J Clin Nutr 1990; 51: 241–247
   Google Scholar
• Gabriel C. Dielectric properties of biological materials. Bioengineering and Biophysical Aspects of Electromagnetic Fields, B Barnes, FS, Greenebaum. CRC Press. 2006; 52–100
   Google Scholar
• Malaescu I, Marin CN. Study of magnetic fluids by means of magnetic spectroscopy. Physica B 2005; 365: 134–140
   Web of Science ®Google Scholar
• Bicknese S, Periasamy N, Shohet SB, Verkman AS. Cytoplasmic viscosity near the cell plasma membrane: Measurement by evanescent field frequency-domain microfluorimetry. Biophys J 1993; 65: 1272–1282
   PubMedGoogle Scholar
• Kline TL, Xu YH, Jing Y, Wang JP. Biocompatible high-moment FeCo-Au magnetic nanoparticles for magnetic hyperthermia treatment optimization. J Magn Magn Mater 2009; 321: 1525–1528
   Web of Science ®Google Scholar